Myocardial Steatosis Among Antiretroviral Therapy–Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial

BACKGROUND: People with human immunodeficiency virus (PWH) face increased risks for heart failure and adverse heart failure outcomes. Myocardial steatosis predisposes to diastolic dysfunction, a heart failure precursor. We aimed to characterize myocardial steatosis and associated potential risk fact...

詳細記述

保存先:
書誌詳細
出版年:J Infect Dis
主要な著者: Neilan, Tomas G, Nguyen, Kim-Lien, Zaha, Vlad G, Chew, Kara W, Morrison, Leavitt, Ntusi, Ntobeko A B, Toribio, Mabel, Awadalla, Magid, Drobni, Zsofia D, Nelson, Michael D, Burdo, Tricia H, Van Schalkwyk, Marije, Sax, Paul E, Skiest, Daniel J, Tashima, Karen, Landovitz, Raphael J, Daar, Eric, Wurcel, Alysse G, Robbins, Gregory K, Bolan, Robert K, Fitch, Kathleen V, Currier, Judith S, Bloomfield, Gerald S, Desvigne-Nickens, Patrice, Douglas, Pamela S, Hoffmann, Udo, Grinspoon, Steven K, Ribaudo, Heather, Dawson, Rodney, Goetz, Matthew Bidwell, Jain, Mamta K, Warner, Alberta, Szczepaniak, Lidia S, Zanni, Markella V
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Supplement Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347082/
https://ncbi.nlm.nih.gov/pubmed/32645158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa245
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料